StockData
Supernus, Inc. logo

Supernus, Inc. (SUPN) income statement

SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$39.84+1.96 (+5.17%)

Close on Oct 19, 2026Market cap $4.86BP/E 11.2Yield –

See a number that looks wrong?